(MedPage Today) -- The perceived danger of catastrophic bleeding in the absence of an antidote for the novel oral anticoagulants (NOACs) appears to be impeding their use for stroke prevention, although that fear is overblown, a researcher said. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment